Buying Time
On Breakthroughs in Age Reversal Technologies
David Sinclair thinks aging is a software problem.
Sinclair is a Harvard geneticist, an Australian transplant to Boston, and one of the most prominent voices in the longevity science world. He has spent decades studying why we age, and he believes he’s found the answer. It’s not that our DNA breaks down over time, which is what most people assume. The genetic code itself, he argues, stays mostly intact throughout our lives. What degrades is something else: the system that tells our cells how to read that code.
He uses an analogy that’s helpful. Think of your DNA as a compact disc (or a vinyl record, if you prefer). The music on the disc is your genetic information, the instructions for building and maintaining your body. When you’re young, the disc plays cleanly. Every cell hears the right song for its job: liver cells play liver music, brain cells play brain music, skin cells play skin music. But over time, the surface of the disc gets scratched. The music is still there, encoded in the grooves, but the scratches cause it to skip. Cells start playing the wrong songs, or playing them poorly. A liver cell begins to forget that it’s a liver cell. A neuron starts losing its way. That, Sinclair argues, is what aging actually is. Not damage to the music, but damage to the reader.
The technical term for this reader is the epigenome, the layer of chemical tags and switches that sit on top of your DNA and control which genes are active in which cells and when. Over a lifetime, these tags get shuffled, misplaced, corrupted. Cells lose their identity. Tissues deteriorate. You age.
Here’s where it gets remarkable. Sinclair’s lab has discovered that cells appear to keep a backup copy of their original settings. Somewhere in the cell, the young version of the epigenome is still stored, like an uncorrupted file on a hard drive. And they’ve found a way to access it.
The technique involves delivering three specific genes into aged cells. These genes (known by the shorthand OSK) are borrowed from the toolkit that stem cells use during embryonic development. When introduced into an old cell, they don’t rewrite the DNA. They do something subtler and, in a sense, more extraordinary: they tell the cell to consult its backup copy and restore its original settings. The scratches get polished off. The music plays clean again.
In mice, the results have been dramatic. Old, blind mice regained their sight. Their retinal cells, which had deteriorated with age, reverted to a younger state. Within four weeks of treatment, elderly mice had visual acuity comparable to young ones. Brain tissue grew sharper. Muscles and kidneys showed signs of rejuvenation. The cells didn’t just stop aging. They went backward.
Sinclair’s company, Life Biosciences, won FDA approval in early 2026 to begin the first human trial of this approach, initially targeting patients with vision loss from conditions like glaucoma. If it works, the implications extend far beyond eyesight. Sinclair has said publicly that he expects age-reversing pills to be available within the next decade, potentially reducing biological age by half or more. At the World Government Summit in early 2026, he stated flatly that “aging could soon be reversible.”
Whether or not that timeline proves optimistic, the underlying science is real and advancing quickly. We are, for the first time in history, seriously developing the ability to make old things young again.
And that fact turns out to be more ancient than it sounds.
Most modern readers, when they encounter the ages listed in Genesis 5, assume they’re reading something symbolic or legendary. Adam lived 930 years. Seth lived 912. Methuselah, the longest-lived
